UBS downgraded its rating on Genesis Minerals after the gold miner reiterated its upgraded production guidance on Thursday, ...

Emerging market stocks have fallen 10% since October amid fears of a new trade war, but markets are still not fully pricing ...

Stocks struggled to make headway after a solid rally, while bond yields dropped on dovish remarks from Federal Reserve ...

The U.S. Department of Labor has given UBS (UBS) a waiver that it needs to continue managing U.S. retirement plans after a paperwork error had ...

UBS has downgraded Regeneron Pharmaceuticals Inc (NASDAQ:REGN) to "Neutral" from "Buy" given uncertainty around its key Eylea franchise. Brokerage slashed price target to $738 from $1130.

UBS Financial Services noted that Argentina has achieved a significant economic turnaround, eliminating a fiscal deficit that exceeded 4% of GDP within a single year. This turnaround has led to a ...

Small- and mid-sized companies have consistently trailed large caps, but UBS believes that may change. Here are 40 top ...

The U.S. Department of Labor granted UBS a waiver the Swiss bank needs to continue managing U.S. retirement plans after a ...

UBS analyst Patrick Rafaisz upgraded Forbo Holding AG (FORN:SW) stock from Neutral to Buy, despite lowering the price target ...

The choppy start to 2025 for the stock market has not been caused by any fundamentally negative economic news, and underlying trends remain favorable for equities, according to Solita Marcelli, chief ...

US stocks surged on Wednesday, fueled by a slowdown in core inflation and better-than-expected earnings from major banks.

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...